COIOS
Deep risk insights through multi-disciplinary research across the globe
  • 12 posts this week
  • 21 drivers moved
  • 3 trackers refreshed
  • Releases this week

Official figures

Where the evidence stands

  • established mixed
    Smoking and vaping

    How far smoking has fallen and how many deaths it still causes, what vaping is doing to the people who take it up and to the people who quit with it, and what the first generational bans will show.

    No papers yet
  • building strengthening
    What changes behaviour at scale

    What moves a population's behaviour — price, defaults, availability, incentives, information — and what the evidence on vaccination, screening and adherence says about which of them work.

    No papers yet
  • established mixed
    Social connection

    How much isolation and loneliness shorten lives, how far the association is causal, and whether anything has been shown to change it.

    2 papers
  • established strengthening
    Inequalities in health and length of life

    Whether inequalities in health and length of life are widening, where, and what is happening to health at working ages.

    1 paper
  • emerging strengthening
    Capacity, funding and care

    What waiting, workforce shortage and the slowing growth of health and care spending cost in lives, how societies are paying for and providing care for older people, and where the evidence for both comes from.

    2 papers
  • established mixed
    Diet and physical activity

    What people eat and how much they move, what the measured evidence says each does to how long they live, and what has been shown to change either.

    No papers yet
  • established mixed
    Alcohol, drugs and suicide

    What is happening to deaths from alcohol, drugs and suicide, whether they move together, and how much of it is behaviour and how much circumstance.

    No papers yet
  • established strengthening
    Environment: air, heat, cold

    What air pollution, heat and cold do to how long people live, how the attribution is made, and which way the net effect is moving.

    1 paper
  • building mixed
    Frailty and multimorbidity at the oldest ages

    Whether the years added after 85 are healthy ones, how frailty and multiple conditions are measured, and where the limits of the data lie.

    No papers yet
  • building strengthening
    Migration and population change

    How far fertility has fallen below what was projected, how migration has become the assumption that moves projections most, and what both do to the mortality statistics.

    No papers yet
  • building strengthening
    New medicines

    Which new drugs and vaccines could plausibly move how long people live, whether they reach the people who would benefit, and what the record says about medicines and life expectancy.

    No papers yet
  • building strengthening
    What linked data reveals

    What linked registries are making it possible to know about whole populations

    No papers yet
  • established steady
    Infectious disease and pandemics

    Infectious disease and pandemics: what they now cost in deaths, and how well we are defended

    1 paper
  • emerging mixed
    Medicine out of hospital

    What wearables, remote monitoring and care at home add to how health is measured and delivered, and whether it shows in outcomes.

    No papers yet
  • emerging strengthening
    AI in medicine

    Whether machine learning predicts, detects and decides better than the tools we have, and whether that has yet changed an outcome for a population.

    No papers yet
  • emerging strengthening
    Biotechnology against inherited risk and ageing

    Whether genomic risk prediction is good enough to use on whole populations, what gene therapies can now do and at what cost, and whether anything yet slows ageing itself.

    1 paper
  • building mixed
    Measuring and projecting life expectancy

    How the numbers are made, how much they revise their own past, and how well mortality can be forecast — and by whom.

    No papers yet
  • contested mixed
    Dementia

    Whether dementia is becoming more or less common, what is found earlier and why that clouds the count, what treatment and prevention now do, and what the deaths say.

    No papers yet
  • building strengthening
    Obesity, diabetes and the GLP-1 drugs

    How far obesity and diabetes are still rising, what is found earlier, what the new drugs do at population scale and who takes them, and what the deaths say.

    1 paper
  • building mixed
    Cancer

    Which cancers are rising and which falling, what screening and new tests find earlier, what treatment has done to survival, and what the deaths say.

    3 papers
  • building mixed
    Cardiovascular disease

    Whether deaths from heart disease and stroke have stopped falling, what is found earlier, what treatment and prevention now do, and what the deaths say.

    No papers yet

Squares are papers, coloured by verdict: new confirms refines contradicts

All drivers, by domain

Just in

All items · Data watch · Revisions

Releases this week

Next seven days: ONS weekly deaths (Wed 16); Eurostat excess mortality (Wed 16); ONS monthly deaths (Thu 17); UKHSA all-cause mortality surveillance (Thu 17); CBS Eenzaamheid, in Dutch (Fri 18); Eurostat Healthcare personnel - dentists, pharmacists and physiotherapists (Fri 18). Full calendar

New sources

New sources, datasets and releases will be noted here as they appear.